Abu Dhabi, UAE — January 15, 2026: In a landmark step for the region’s biomedical innovation ecosystem, Abu Dhabi Biobank, a strategic initiative between the Department of Health Abu Dhabi and M42, has entered a collaboration with AstraZeneca, a global science-led biopharmaceutical leader, to advance the fields of precision medicine, translation of clinical research into clinical practices.